Mathematical Model Predicts Promising Drug Combinations for Heart Attack Treatment

A team at Ohio State University has built something that exists nowhere in nature: a mathematical portrait of a heart attack, rendered in differential equations and tested on mice. The work, published in the Journal of Theoretical Biology, represents an attempt to do something medicine has struggled with for decades—predict which drug combinations will actually work to save heart tissue after the blood supply cuts off.

Heart attacks strike more than 800,000 Americans each year. About one in three of them die. For those who survive, the damage is not finished. The heart muscle itself is scarred, permanently weakened. In the days and weeks after the attack, the body's own immune system—meant to protect—turns destructive, flooding the damaged area with inflammation that spreads the injury further. Doctors can restore blood flow through surgery or medication, a process called reperfusion therapy. But controlling what happens next, controlling the immune response itself, remains a puzzle with no perfect answer.

Nicolae Moise, a postdoctoral researcher in biomedical engineering, led the effort to build a model that could test drug combinations before they ever touch a human patient. His team took data from previous animal studies and constructed a series of equations that track how specific immune cells—myocytes, neutrophils, macrophages—respond to four different immunomodulatory drugs over the course of a month. These drugs are designed to suppress the immune system's most destructive impulses, to let the heart heal without the body attacking itself. The model simulates what happens in the first hour after treatment, watching how different drug combinations perform against inflammation.

What emerged from the mathematics was unexpected: certain combinations of these inhibitors worked better than others at reducing inflammation. Some pairings were simply more efficient. Moise describes the work as a translation exercise. "Biology and medicine are starting to become more mathematical," he said. "There's so much data that you need to start integrating it into some kind of framework." The framework he and his colleagues built is, by their account, the most detailed mathematical schematic of heart attacks in mice ever attempted.

The implications are significant but distant. A person recovering from a heart attack typically needs six to eight months to heal, and those first few weeks are critical—the quality of care then can determine the entire trajectory of recovery. If doctors could predict which drug combination would work best for a particular patient, before inflammation takes hold, the difference could be substantial. But Moise is careful about timelines. The model is theoretical. It needs more precise data from animal studies before other scientists can use it. Clinical application, he estimates, is years away.

What matters now is that the first step has been taken. A mathematical language for describing what happens inside a damaged heart has been written. The equations are there. The logic is there. The hard work of turning theory into practice—of moving from mice to humans, from simulation to bedside—remains ahead. But for a disease that kills a quarter-million Americans annually, even the promise of a better way to choose which drugs to give, and when, is worth the long wait.